Presentaties 1st Dutch Thrombosis Academy 30 juni 2022

12.30 - 13.00 hours  Registration and welcome with lunch
                                     
13.00 - 13.05 hours Opening
Dutch Thrombosis Network 
   
Session 1: Atypical site Thrombosis: Splanchnic Vein Thrombosis - Cerebral Vein Thrombosis - hic sunt leones
Chairs:   Prof. dr. Pieter Willem Kamphuisen – Tergooi/Amsterdam UMC
Prof. dr. Karina Meijer – UMCG
   
13.05 - 13.25 hours Diagnosis: Greek god studies with MRDTI
Cindy de Jong – LUMC
   
13.25 - 13.30 hours Discussion
   
13.30 - 14.00 hours Debate: Treatment of atypical site thrombosis with DOAC, LMWH or VKA
Dr. Erik Klok – LUMC: DOACs 
versus
Prof. dr. Frank Leebeek – Erasmus MC: LMWH/VKA
   
Session 2: Thrombosis research in the general practitioners area
Chairs: Prof. dr. Menno Huisman – LUMC
Dr. Erik Klok – LUMC
   
14.00 - 14.20 hours Prevalence dependent diagnostic strategies for pulmonary embolism
Dr. Geert Jan Geersing – UMC Utrecht
   
14.20 – 14.40 hours Point-of-Care D-dimer testing: friend or foe?
Dr. Wim Lucassen – Amsterdam UMC
   
14.40 - 14.50 hours Discussion
   
14.50 - 15.20 hours BREAK
   
Session 3: Acute treatment of VTE – trials update
Chairs: Dr. Michiel Coppens – Amsterdam UMC
Dr. Geert-Jan Geersing – UMC Utrecht
   
15.20 - 15.50 hours Hi-Peitho and Peitho-3 studies in intermediate risk pulmonary embolism
Dr. Stefano Barco – Unispital Zürich Zwitserland
   
15.50 - 16.05 hours Safe-SPPE study 
Prof. dr. Menno Huisman – LUMC
   
16.05 - 16.20 hours L-TriPP study
Louise Burggraaf – LUMC
   
16.20 - 16.35 hours Discussion
   
16.35 - 16.50 hours Dutch Covid & thrombosis Coalition: update of research 
Chantal Visser – Erasmus MC
   
16.50 – 17.10 hours Lessons to be learned from trials 
Rosanne van Maanen – UMC Utrecht
Dieuwke Luijten – LUMC
   
17.10 – 17.25 hours Discussion
   
17.25 - 18.45 hours BREAK for drinks and dinner
   
Session 4: Novel antithrombotics and niches for treatment
Chairs: Prof. dr. Hugo ten Cate – Maastricht UMC+
Dr. Wim Lucassen – Amsterdam UMC
   
18.45 - 19.15 hours Factor XI inhibition – look back and Anthos trials
Dr. Nick van Es – Amsterdam UMC
   
19.15 - 19.30 hours Discussion
   
19.30 - 20.00 hours Thrombosis and pregnancy – High Low study, ALIFE2 study and more
Prof. dr. Saskia Middeldorp – Radboudumc
   
20.00 - 20.15 hours Discussion
   
Session 5:  
   
20.15 – 21.00 hours Thrombosis research pitches by young investigators
   
21.00 – 21.15 hours DTN: Plans for the near future
   
21.15 - 21.30 hours Closing words